Sybody candidates compete for ACE2 binding onto SARS-CoV-2 spike RBD

In this technical note, Creoptix AG shows how the WAVEsystem can be used to understand the binding dynamics of Sybody^® candidates to the receptor binding domain (RBD) of SARS-CoV-2, both provided by Linkster Therapeutics AG and the University of Zürich.